Wells Fargo
GRCL

Wells Fargo’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Wells Fargo’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,194
Closed -$72.2K – 7789
2023
Q4 		$72.2K Buy
7,194
+440
+7% +$2K ﹤0.01% 5102
2023
Q3 		$19.5K Sell
6,754
-3,455
-34% -$12.6K ﹤0.01% 5611
2023
Q2 		$38.9K Buy
10,209
+5,685
+126% +$15.9K ﹤0.01% 5519
2023
Q1 		$8.41K Buy
4,524
+894
+25% +$1.87K ﹤0.01% 5915
2022
Q4 		$8.35K Sell
3,630
-1,000
-22% -$3.06K ﹤0.01% 5620
2022
Q3 		$15K Sell
4,630
-510
-10% -$1.66K ﹤0.01% 5536
2022
Q2 		$28K Sell
5,140
-4,400
-46% -$13.7K ﹤0.01% 5290
2022
Q1 		$22K Buy
9,540
+3,630
+61% +$12.4K ﹤0.01% 5983
2021
Q4 		$36K Sell
5,910
-7,554
-56% -$72.6K ﹤0.01% 6128
2021
Q3 		$187K Buy
13,464
+13,454
+134,540% +$159K ﹤0.01% 5127
2021
Q2 		$0 Sell
10
-7,702
-100% -$103K ﹤0.01% 7646
2021
Q1 		$119K Buy
+7,712
New +$182K ﹤0.01% 5408

Wells Fargo's GRCL Position: Q1 2024 in Review

Wells Fargo sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 7,194 shares — an estimated $72.2K sold.

Wells Fargo first reported a position in GRCL in Q1 2021 and held it in 12 quarters. The position peaked at $187K in Q3 2021. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

  • Wells Fargo reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 7,194 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $72.2K.
  • Wells Fargo first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 12 quarters.
  • Wells Fargo's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $187K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.